Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

158 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Post-treatment strategies for pyrophoric KOH-activated carbon nanofibres.
Fischer T, Kretzschmar A, Selmert V, Jovanovic S, Kungl H, Tempel H, Eichel RA. Fischer T, et al. Among authors: kretzschmar a. RSC Adv. 2024 Jan 25;14(6):3845-3856. doi: 10.1039/d3ra07096d. eCollection 2024 Jan 23. RSC Adv. 2024. PMID: 38274173 Free PMC article.
How microstructures, oxide layers, and charge transfer reactions influence double layer capacitances. Part 1: impedance spectroscopy and cyclic voltammetry to estimate electrochemically active surface areas (ECSAs).
Schalenbach M, Selmert V, Kretzschmar A, Raijmakers L, Durmus YE, Tempel H, Eichel RA. Schalenbach M, et al. Among authors: kretzschmar a. Phys Chem Chem Phys. 2024 May 15;26(19):14288-14304. doi: 10.1039/d3cp04743a. Phys Chem Chem Phys. 2024. PMID: 38693897
Inflammatory stress determines the need for chemotherapy in patients with HER2-positive esophagogastric adenocarcinoma receiving targeted and immunotherapy.
Tintelnot J, Paschold L, Goekkurt E, Schultheiss C, Matschl U, Santos Cruz M, Bauer M, Wickenhauser C, Thuss-Patience P, Lorenzen S, Ettrich TJ, Riera-Knorrenschild J, Jacobasch L, Kretzschmar A, Kubicka S, Al-Batran SE, Reinacher-Schick A, Pink D, Bokemeyer C, Sinn M, Lindig U, Hinke A, Hegewisch-Becker S, Stein A, Binder M. Tintelnot J, et al. Among authors: kretzschmar a. Cancer Immunol Res. 2024 Nov 11. doi: 10.1158/2326-6066.CIR-24-0561. Online ahead of print. Cancer Immunol Res. 2024. PMID: 39527097
Subgroup analyses from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR trial.
Karthaus M, Heinemann V, Riera-Knorrenschild J, Kretzschmar A, Welslau M, Kaiser U, Pelz H, Ettrich TJ, Held S, Kehmann L, Hess J, Reisländer T, Weiss L; TALLISUR study group. Karthaus M, et al. Among authors: kretzschmar a. BMC Cancer. 2024 Jul 23;24(1):887. doi: 10.1186/s12885-024-12599-7. BMC Cancer. 2024. PMID: 39044160 Free PMC article. Clinical Trial.
Nanoliposomal irinotecan and fluorouracil plus leucovorin versus fluorouracil plus leucovorin in patients with cholangiocarcinoma and gallbladder carcinoma previously treated with gemcitabine-based therapies (AIO NALIRICC): a multicentre, open-label, randomised, phase 2 trial.
Vogel A, Saborowski A, Wenzel P, Wege H, Folprecht G, Kretzschmar A, Schütt P, Jacobasch L, Ziegenhagen N, Boeck S, Zhang D, Kanzler S, Belle S, Mohm J, Gökkurt E, Lerchenmüller C, Graeven U, Pink D, Götze T, Kirstein MM. Vogel A, et al. Among authors: kretzschmar a. Lancet Gastroenterol Hepatol. 2024 Aug;9(8):734-744. doi: 10.1016/S2468-1253(24)00119-5. Epub 2024 Jun 10. Lancet Gastroenterol Hepatol. 2024. PMID: 38870977 Free article. Clinical Trial.
158 results